Employee Benefits
Specialty Rx
White Paper
Since the 1990s, the number of specialty drugs available on the market has increased exponentially. Employer-sponsored health plans have seen a rise in pharmacy expense due to the increasing availability and costs of these medications. As a result, employers are seeking ways to curb specialty Rx spend.
Download this white paper to learn:
- Approaches to reducing spending
- Compliance and regulatory consequences of those approaches
- Possible solutions and considerations
Related Insights

M&A and Transaction Solutions
Moving at the Speed of M&A: Insurance Due Diligence
September 28, 2023
Read More

Captives
Mapping the Journey to a Successful Captive
September 27, 2023
Read More

Press Release
Hylant Expands Global Captive Solutions Team with Four New Hires
September 26, 2023
Read More